Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Lewis

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1993
A humanized CD18 antibody can block function without cell destructionM J Sims, D G Hassal, S Brett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Rescue, expression, and analysis of a neutralizing human anti-hepatitis A virus monoclonal antibodyA P Lewis, S M Lemon, K A Barber, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Clinical and Experimental Immunology|July 17, 2015
Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1J C Cordy, P J Morley, T J Wright, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studiesJ M Barnett, A Cadman, D Gor, et al.
The Journal of Biological Chemistry|October 24, 2000
Proteomics characterization of abundant Golgi membrane proteinsA W Bell, M A Ward, W P Blackstock, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1993
A humanized CD18 antibody can block function without cell destructionM J Sims, D G Hassal, S Brett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Rescue, expression, and analysis of a neutralizing human anti-hepatitis A virus monoclonal antibodyA P Lewis, S M Lemon, K A Barber, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Clinical and Experimental Immunology|July 17, 2015
Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis factor-α receptor 1J C Cordy, P J Morley, T J Wright, et al.
Antimicrobial Agents and Chemotherapy|December 22, 1999
Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studiesJ M Barnett, A Cadman, D Gor, et al.
The Journal of Biological Chemistry|October 24, 2000
Proteomics characterization of abundant Golgi membrane proteinsA W Bell, M A Ward, W P Blackstock, et al.
Pageof 3